Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Liraglutide for Sale > Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer buy - large image1
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer buy - image1
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer buy - image2
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer buy - image3
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer buy - image4
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer buy - image5
Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer buy - image6

Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer

TDS 29 Inquiries

Unit Price:

$50/UNIT FOB

Get Latest Price
CAS No.:

204656-20-2

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

10mg/Vial

Price valid (until):

2026-10-03

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  



          • LL5 5 mg — Product Details

            Product Overview

            LL5 5 mg is a laboratory and research-use product supplied in a 5 mg package specification. The product is intended for qualified professional users and organizations engaged in legitimate laboratory, analytical, research, development, or other professional activities, subject to all applicable laws, regulations, and institutional requirements.

            The designation “LL5” and the 5 mg package specification alone are not sufficient to establish the complete chemical identity or regulatory classification of the product. The exact product identity, including the full chemical name, CAS number, composition, specification, and applicable documentation, should therefore be confirmed before purchase or use.

            This product description is provided for general product-reference and commercial information only. It does not replace the applicable Safety Data Sheet (SDS), Certificate of Analysis (COA), technical specification, official labeling, regulatory documentation, or professional safety assessment.

            Product Information

            Product Name: LL5
            Package Size: 5 mg
            Product Type: Laboratory and research-use product
            Grade: Subject to the applicable product specification
            Purity: Subject to the applicable batch-specific COA or specification
            CAS Number: To be confirmed according to the exact product identity
            Molecular Formula: To be confirmed according to the exact product identity
            Molecular Weight: To be confirmed according to the exact product identity
            Appearance: Subject to the applicable product specification

            The exact technical parameters should always be verified against the official documentation supplied for the specific product and batch.

            Intended Professional Use

            LL5 5 mg is offered for legitimate professional and research-related purposes where permitted by applicable laws and regulations.

            The product should only be handled and used by appropriately trained personnel in suitable facilities and under procedures appropriate for the actual properties and hazards of the material.

            The supplier does not recommend or represent the product for medical, therapeutic, diagnostic, nutritional, household, recreational, or other applications unless such use is expressly authorized and supported by applicable regulatory approvals and official product documentation.

            Customers are responsible for determining whether the product is suitable and legally permitted for their intended application.

            Quality and Traceability

            Product quality is managed according to applicable manufacturing and quality-control procedures. Product specifications and batch-related information should be verified through the relevant technical documentation.

            Depending on the product, order requirements, and applicable regulations, supporting documents may include:

            • Certificate of Analysis (COA)

            • Safety Data Sheet (SDS), where applicable

            • Product specification

            • Batch or lot information

            • Packaging information

            • Labeling information

            • Other documentation required for a specific transaction or jurisdiction

            Documentation availability may depend on the product, batch, destination, customer qualifications, and applicable regulatory requirements.

            Customers should review the available documentation before ordering and confirm that it meets their institutional, regulatory, and application requirements.

            Regulatory Compliance

            The regulatory status of a chemical product must be determined according to its exact identity, composition, concentration, physical form, packaging, intended transaction, destination, and applicable jurisdiction.

            If LL5 5 mg is subject to hazardous-chemical controls or other regulatory requirements in a particular jurisdiction, all applicable requirements remain fully applicable.

            Such requirements may include, where applicable, supplier or purchaser qualifications, licensing, registration, documentation, labeling, storage, transportation, import or export controls, end-use requirements, and other relevant compliance obligations.

            This product description does not attempt to change, conceal, minimize, or circumvent any regulatory classification.

            Product names, abbreviations, internal references, package sizes, or commercial descriptions must not be used as a substitute for the actual chemical identity or as a means of avoiding regulatory requirements.

            Where a transaction requires verification of qualifications or supporting documentation, the transaction may be reviewed before confirmation.

            If required qualifications or documents cannot be satisfactorily verified, the supplier may decline, suspend, or delay the transaction.

            Safety and Handling

            Customers should obtain and review the applicable SDS and product-specific safety information before handling LL5 5 mg.

            The actual handling requirements must be determined from the official documentation for the exact product supplied.

            Appropriate laboratory and workplace safety procedures should be followed, including suitable engineering controls, personal protective equipment, exposure controls, storage procedures, and emergency measures as applicable to the material.

            Users should not rely solely on this general product description to determine whether the product is hazardous or to establish appropriate handling procedures.

            If the product is classified as hazardous under applicable regulations, the relevant hazard communication, precautionary measures, storage, transportation, spill response, disposal, and other requirements must be followed.

            Storage

            Storage conditions should be determined according to the official product specification and applicable SDS.

            Where appropriate, the product should remain in its original, properly identified packaging and should be stored under the conditions specified by the manufacturer.

            Users should maintain appropriate product identification and traceability and prevent unauthorized access.

            Storage arrangements should comply with applicable laboratory, workplace, environmental, and chemical-safety requirements.

            Packaging and Delivery

            LL5 5 mg is supplied according to the applicable packaging specification.

            The packaging and labeling should correspond to the actual product and applicable transaction requirements. Customers should verify the product name, quantity, batch or lot information, labeling, and accompanying documentation upon receipt where applicable.

            Customers should inspect the package for visible damage or other irregularities before use. If there is a discrepancy involving the product identity, quantity, packaging, labeling, or documentation, customers should contact the supplier before using the product.

            Transportation arrangements, where applicable, must comply with the requirements associated with the actual classification of the product and the destination jurisdiction.

            No shipping method or product description should be interpreted as overriding applicable dangerous-goods or chemical-transportation requirements.

            Ordering Requirements

            Before placing an order, customers should confirm the following:

            1. The complete and accurate identity of the product.

            2. The required package size and specification.

            3. The applicable regulatory status in the destination jurisdiction.

            4. Whether the purchaser is qualified or authorized to purchase or receive the product.

            5. Whether supporting documents or permits are required.

            6. Whether import, export, transportation, storage, possession, or end-use restrictions apply.

            7. Whether the customer's intended use is permitted under applicable laws and institutional policies.

            For regulated products, additional information or documentation may be requested during the order-review process.

            The supplier may request appropriate qualification documents where required by law, regulation, platform policy, or transaction conditions.

            Documentation

            Customers requiring technical or compliance documentation should request the relevant documents before completing the transaction.

            Documents should correspond to the exact product and, where applicable, the relevant batch or lot.

            Customers should ensure that documents are current and suitable for the jurisdiction and application in which the product will be used.

            Where regulatory documentation is required, the absence of such documentation may prevent a transaction from being completed.

            Compliance Statement

            The supplier intends to provide product information in a manner consistent with applicable laws, regulations, marketplace requirements, and chemical-safety principles.

            No information contained in this listing is intended to misrepresent the identity, composition, classification, regulatory status, or intended use of the product.

            Where applicable regulations require purchaser qualifications, permits, registrations, or supporting documentation, customers remain responsible for satisfying those requirements.

            If marketplace review requires additional information or qualification documents, the supplier should provide the requested materials through the appropriate platform process rather than attempting to modify the product description to avoid review.

            Disclaimer

            The information provided in this listing is general product information and should not be regarded as legal, regulatory, medical, or safety advice.

            Regulatory classifications and requirements may vary by jurisdiction and may change over time. Customers should independently confirm the requirements applicable to their location, transaction, and intended use.

            In case of any discrepancy between this general description and official product documentation, the applicable official documentation should take precedence.

            Customers should consult the relevant SDS, COA, technical specification, official labeling, and regulatory documentation before purchase, handling, storage, transportation, or use.

            The supplier reserves the right to request additional information, qualification documents, or regulatory confirmation when required.

            Customer Service

            For questions regarding product identity, technical specifications, documentation, packaging, or regulatory requirements, customers should contact the supplier before placing an order.

            When contacting the supplier, customers should provide sufficient information to allow accurate confirmation of the requested product and transaction requirements.

            LL5 5 mg should be purchased, handled, stored, transported, and used only by appropriately qualified users and in accordance with the applicable laws, regulations, safety procedures, official product documentation, and marketplace requirements.

    Items Specifications
    Product Name LL5
    Grade Research Grade
    Package 5mg/Vial
    Appearance White Lyophilized Powder
    Model LL5 5mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference
    Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
    Liraglutide is characterized as a white to almost white powder. It is freely soluble in aqueous base solutions (> 270 mg/mL), but its water solubility decreases below pH 7 and reaches its lowest level at pH 4-5 (approximately 0.05 mg/mL). Solubility increases marginally at pH 2.5 where it is very slightly soluble (≤ 0.8 mg/mL). Liraglutide is soluble in methanol (68 mg/mL) and very slightly soluble in ethanol (1.1 mg/mL). The isoelectric point of liraglutide is approximately 4.9. The pH of a 1 mg/mL aqueous solution of drug substance is approximately 9.3.
    ChEBI: Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.
    Liraglutide is GLP-1(1–37) modified at Ly: the -amino group is acylated with an (N-hexadecanoyl)glutam- -yl moiety that noncovalently but avidly binds tohuman serum albumin. (Also, Lys is conservatively replacedwith Arg.) These changes provide for a greatly extendedserum t12 of~10 to 15 hours after sc administration(0.6–1.8 mg), allowing for once-daily dosing.Liraglutide (Victoza, Novo Nordisk) is awaiting approvalby the FDA, EMEA, and the Koˉ roˉ -shoˉ (Japan).
    Liraglutide peptide is a single, non-glycosylated polypeptide chain containing 31 amino acids, having a molecular mass of 3751 Dalton and a Molecular formula of C172H265N43O51.

    Certificates
    • Liraglutide LL5 Research Grade Peptides Peptide Raw Material Manufacturer Certificates 1 TDS

    Basic Info
    Product Name:

    Liraglutide

    Other Name:

    Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide

    CAS No.:

    204656-20-2

    Molecular Formula:

    C172H265N43O51

    InChIKeys:

    YSDQQAXHVYUZIW-VTFFJMQZNA-N

    Molecular Weight:

    3751.202

    Exact Mass:

    3748.95000

    EC Number:

    810-818-7

    Color/Form:

    White to Off-White

    Characteristics
    PSA:

    1513.76000

    XLogP3:

    6.12960

    Melting Point:

    >182°C (dec.)

    Critical Temperature & Pressure:

    Refrigerator

    Research
    Class:

    GLP-1 receptor agonist (acylated GLP-1 analog, 31-amino-acid peptide)

    Status:

    FDA-approved (Victoza 2010, Saxenda 2014 for obesity)

    Mechanism:

    A 31-amino-acid GLP-1 analog with a C16 fatty-acid chain (palmitoyl) attached to Lys26 via a gamma-glutamic acid spacer. This fatty-acid modification enables reversible binding to serum albumin, extending the half-life to ~13 hours and allowing once-daily dosing. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite.

    EC50 (GLP1R Ec50):

    ~10 nM

    Source:

    DrugBank: DB06655; Knudsen LB, et al. J Med Chem. 2000;43(9):1664-1669.DOI

    Clinical Development:

    NCT00781922; NCT01272219

    FDA:

    Victoza, Saxenda (approved 2010-01-25)

    References
    ChEMBL:

    CHEMBL1213363

    DrugBank:

    DB06655

    KEGG DRUG:

    D09199

    PubChem:

    PubChem

    Disclaimer:

    Liraglutide is FDA-approved as a prescription medicine (Victoza for T2DM, Saxenda for obesity). This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    29 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    China factory wholesale price supply high purity 99% cas 204656-20-2 Liraglutide injection

    50 KG Sep 30, 2023
    India

    Liraglutide

    1.00 KG Oct 8, 2024
    India

    Liraglutide-USP

    150.00 G Oct 10, 2023
    United Kingdom

    Liraglutide

    20 MG Jul 8, 2026
    United States

    MIC

    2 MT May 20, 2026
    United States

    Mic (Lipo C with B12), VIP, Ss31, glutathione and, Reta

    50 MG Mar 4, 2026
    Canada

    Liraglutide

    1 KG Dec 8, 2025
    United States

    liraglutide

    1 MT Nov 22, 2025
    Brazil

    Liraglutida

    1 G Sep 29, 2025
    United States

    Liraglutide

    1 KG Aug 13, 2025
    Sweden

    liraglutide

    1 KG Aug 4, 2025
    Pakistan

    liraglutide injection

    50 KG Jan 21, 2025
    India

    Liraglutide

    10 MG Jul 17, 2024
    United States

    Peptide Liraglutide/Victoza/Liraglutida 98% Powder 67-51-6 Weight Loss Senwayer

    1 KG Sep 30, 2023
    Jordan

    Liraglutide

    1.00 MT Sep 19, 2023
    India

    liraglutide

    1 KG Feb 25, 2026
    United States

    liraglutide

    Jan 21, 2026
    Reunion Island

    Liraglutide

    1 G Apr 14, 2025
    United States

    Liraglut

    1 MT Feb 9, 2025
    Israel

    Liraglutide

    1 G Aug 26, 2024
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.